74 results
Keyword Phentermine Remove keyword
-
List item
Human medicine European public assessment report (EPAR): Qsiva
phentermine, topiramate, Obesity
Date of refusal: 14/05/2013, Refused, Last updated: 13/06/2013Refused phenterminetopiramate Overview On 18 October 2012 … contains the active substances phentermine and topiramate. It was to … are appetite suppressants. Phentermine suppresses appetite by releasing … -
List item
Opinion/decision on a Paediatric investigation plan (PIP): phentermine, topiramate
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Endocrinology-Gynaecology-Fertility-Metabolism
PIP number: EMEA-000826-PIP01-09, Route(s) of administration: Oral use, Pharmaceutical form(s): Capsule, hard
Decision date: 29/10/2010, Last updated: 25/11/2010, Compliance check: XActive substance phentermine topiramate Therapeutic area … granting of a waiver for phentermine / topiramate, (EMEA-000826-PIP01-09 … granting of a waiver for phentermine / topiramate, (EMEA-000826-PIP01-09 … -
List item
Referral: Anorectics
phentermine, amfepramome, clobenzorex, dexfenfluramine, fenbutrazate, fenfluramine, fenproporex, mazindol, mefenorex, norpseudoephedrine, phenmetrazine, phendimetrazine, propylhexedrine, Article 31 referrals
Status: European Commission final decision, opinion/position date: 16/02/1996, EC decision date: 09/12/1996, Last updated: 10/12/1996Phendimetrazine, Phenmetrazine, Phentermine • Type II Substances: Dexfenfluramine … 108), Phenmetrazine (109), Phentermine (103) 1/2 Annex I AMENDMENTS … phentermine amfepramome clobenzorex de … -
List item
Referral: Topiramate (updated)
topiramate, Article 31 referrals
Status: Recommendation provided by Pharmacovigilance Risk Assessment Committee, Last updated: 01/09/2023used in combination with phentermine for weight reduction. At … used in combination with phentermine for weight reduction. At … -
List item
News: PRAC starts review of topiramate use in pregnancy and women of childbearing potential
PRAC, Last updated: 02/09/2022countries, in combination with phentermine for body weight reduction … -
List item
News: PRAC recommends new measures to avoid topiramate exposure in pregnancy (new)
PRAC, Last updated: 01/09/2023used in combination with phentermine for weight reduction. At … -
List item
Human medicine European public assessment report (EPAR): Fintepla (updated)
Fenfluramine hydrochloride, Epilepsies, Myoclonic
Date of authorisation: 18/12/2020,
, 
, Revision: 6, Authorised, Last updated: 01/09/2023
-
List item
Human medicine European public assessment report (EPAR): Xenical
orlistat, Obesity
Date of authorisation: 29/07/1998, Revision: 25, Authorised, Last updated: 10/05/2023 -
List item
Human medicine European public assessment report (EPAR): Striascan
ioflupane (123l), Radionuclide Imaging; Dementia; Movement Disorders
Date of authorisation: 25/06/2019,
, Revision: 2, Authorised, Last updated: 05/12/2022
-
List item
Human medicine European public assessment report (EPAR): Nouryant
Istradefylline, Parkinson Disease
Date of refusal: 06/01/2022, Refused, Last updated: 19/01/2022 -
List item
Human medicine European public assessment report (EPAR): Imcivree
Setmelanotide, Obesity
Date of authorisation: 16/07/2021,, , Revision: 7, Authorised, Last updated: 22/03/2023
-
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 18-21 February 2013
CHMP, Last updated: 22/02/2013Qsiva INN phentermine / topiramate Marketing-authorisation … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 15-18 October 2012
CHMP, Last updated: 19/10/2012INN phentermine / topiramate Marketing-authorisation … -
List item
Human medicine European public assessment report (EPAR): Sunosi
solriamfetol hydrochloride, Narcolepsy; Sleep Apnea, Obstructive
Date of authorisation: 16/01/2020,, Revision: 7, Authorised, Last updated: 14/12/2022
-
List item
Human medicine European public assessment report (EPAR): Celsunax
ioflupane (123i), Radionuclide Imaging; Dementia; Movement Disorders
Date of authorisation: 17/06/2021,, Authorised, Last updated: 02/07/2021
-
List item
Human medicine European public assessment report (EPAR): DaTSCAN
ioflupane (123l), Tomography, Emission-Computed, Single-Photon; Lewy Body Disease; Parkinson Disease; Alzheimer Disease
Date of authorisation: 27/07/2000, Revision: 23, Authorised, Last updated: 10/02/2022 -
List item
Human medicine European public assessment report (EPAR): Revatio
sildenafil, Hypertension, Pulmonary
Date of authorisation: 28/10/2005, Revision: 49, Authorised, Last updated: 21/03/2023 -
List item
Human medicine European public assessment report (EPAR): Vafseo
Vadadustat, Renal Insufficiency, Chronic; Anemia
Date of authorisation: 24/04/2023,, Authorised, Last updated: 31/05/2023
-
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 29 August – 1 September 2022
PRAC, Last updated: 02/09/2022countries, in combination with phentermine for body weight reduction … Topiramate (NAP); topiramate, phentermine (NAP) - EMEA/H/A-31/1520 … -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 28-31 August 2023 (new)
PRAC, Last updated: 01/09/2023used in combination with phentermine for weight reduction. At … -
List item
Withdrawn application: Imcivree
setmelanotide, date of withdrawal: 22/04/2022, Post-authorisation, Last updated: 28/09/2022 -
List item
Referral: Amfepramone-containing medicinal products
amfepramone, associated names: Regenon, Tenuate Retard, Amfepramon-Hormosan, Regenon Retard, Article 31 referrals
Status: European Commission final decision, opinion/position date: 10/11/2022, EC decision date: 13/01/2023, Last updated: 20/01/2023 -
List item
Referral: Efexor depot
venlafaxine, Article 30 referrals
Status: European Commission final decision, opinion/position date: 24/07/2008, EC decision date: 28/11/2008, Last updated: 20/12/2008 -
List item
Referral: Efexor
venlafaxine, Article 30 referrals
Status: European Commission final decision, opinion/position date: 24/07/2008, EC decision date: 28/11/2008, Last updated: 18/12/2008 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 5-8 June 2023 (updated)
European Medicines Agency, Amsterdam, the Netherlands, from 05/06/2023 to 08/06/2023, Last updated: 04/09/2023Topiramate (NAP); topiramate, phentermine (NAP) - EMEA/H/A-31/1520 …